Exenatide
The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
AstraZeneca · Phase 3 · Completed · Enrollment 150
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Exenatide | 24 participants | 11 participants | 16 participants | n/r | 0 |
| Placebo | 19 participants | 8 participants | 16 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.